“…Microfluidic platforms have emerged as attractive, powerful, and versatile tools for various biomedical and pharmaceutical applications, including nanomaterial synthesis, drug delivery, vaccine design, cell analysis, personalized medicine development, and diagnosis [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. Among these, the continuous production of monodispersed nanomaterials (including soft lipid and polymer nanoparticles) and hard nanocrystals with controllable sizes and shapes is considered one of the frontline applications of microfluidics in recent years [ 1 , 5 , 7 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ].…”